Hemp and CBD Status Report after passage of the Farm Bill

December 17, 2018

Silver Spring, MD, Dec. 17, 2018 (GLOBE NEWSWIRE) -- Congress passed last week a Farm Bill that includes historic provisions that will legalize hemp, the low THC cultivars of the Cannabis sativa L. species. This landmark legislation will change how hemp and hemp-derived products like cannabidiol (CBD) are regulated in the U.S.

To help the herbal products industry and the media understand the new regulatory landscape, The American Herbal Products Association (AHPA) has produced a Status Report and has scheduled a webinar to answer questions about this change. AHPA experts are also available to answer media inquiries on hemp and CBD.

Status report

AHPA worked with legal and industry experts to develop a new, free resource titled Status Report: Marketing of hemp and cannabidiol (CBD) products in the United States following passage of the 2018 Farm Bill.

This document provides concise and up-to-date information on the status of such operations and products as soon as this legislation is adopted as federal law and taking into account other current and relevant laws and regulations.

Because of the herbal product industry’s broad interest in the impact of this legislation on hemp and CBD, AHPA is distributing this information before the bill has been signed into law. The 2018 Farm Bill has been passed by the Senate and House, but still needs to be signed into law by the President. We are not aware of any indications that successful and timely completion of this is in doubt. AHPA will notify those receiving this information in the unlikely event that circumstances change.


The Dec. 19 webinar will present expert information on how the Farm Bill could affect companies that want to cultivate hemp crops or sell consumer goods that contain hemp and hemp-derived ingredients, including CBD. It will also be a unique opportunity to get answers to your questions on these topics.

Webinar Details

-- o Date: Wednesday, December 19, 2018 o Time: 1:00-3:00 PM EST o Cost: $50 for members -- $100 for non members


Veteran herbal industry experts will provide insiders’ views of the evolving regulatory landscape for companies growing, manufacturing or selling hemp and products with hemp-derived ingredients, including CBD.

-- o Jane Wilson, Director of Program Development, AHPA o Holly Johnson, Ph.D., Chief Science Officer, AHPA o Will Woodlee, Esq., Partner, Kleinfeld, Kaplan & Becker o Pete Evich, Vice President, Van Scoyoc Associates (Q&A) o Tony Young, Esq., Partner, Kleinfeld, Kaplan & Becker (Q&A)

About AHPAThe American Herbal Products Association (AHPA) is the national trade association and voice of the herbal and botanical products industry. AHPA is comprised of more than 300 domestic and foreign companies doing business as growers, processors, manufacturers, and marketers of herbs and herbal products, including foods, dietary supplements, cosmetics, and non-prescription drugs. Founded in 1982, AHPA’s mission is to promote the responsible commerce of herbal products. Website: www.ahpa.org.


-- 18_1212_AHPA_Hemp-CBD_Status_Report_Post_Farm_Bill

Haley Chitty (media inquires) American Herbal Products Association (AHPA) 301-588-1171 x104 communications@ahpa.org Jane Wilson (regulatory and industry inquiries) American Herbal Products Association (AHPA) 301-588-1171 x108 jwilson@ahpa.org Michael McGuffin (regulatory and industry inquiries) American Herbal Products Association (AHPA) 301-588-1171 x201 mmcguffin@ahpa.org Holly Johnson, Ph.D. (science inquiries) American Herbal Products Association (AHPA) 301-588-1171 x103 hjohnson@ahpa.org

Update hourly